KAI-407

N/A

Report date: 2023/01/01 20:06:13

NME

Base Information

Drug NameKAI-407

Drug Alias NameKAI-407

ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Aminoquinoline antibiotics

Mechanisms of ActionHepatitis C virus NS7 protein inhibitors

TargetsHepatitis C virus NS7 protein

Therapy Area/IndicationsMalaria

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesNovartis Pharma Ag

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsMalaria

Inactive IndicationsN/A

ATC CodeN/A